Skip to main content
. Author manuscript; available in PMC: 2015 Jan 30.
Published in final edited form as: Psychiatry Res. 2013 Oct 19;221(1):21–29. doi: 10.1016/j.pscychresns.2013.08.004

Table 1.

Subject Demographics

CHR (n=20) TDC (n=19)

Age (mean ± std) 16.85 (2.06) 17.84 (2.11)
  (range) 14-20 14-21
Gender: % female (n) 15% (3)* 47.36% (9)*
Race: percent (n)
 % Caucasian 50% (10) 42.11% (8)
 % African American 10% (2) 5.2% (1)
 % Asian American/Pacific Islander 15 %(3) 10.5% (2)
 % Latino/Hispanic 20% (4) 10.5% (2)
 % Other 5% (1) 44.4% (4)
Primary SIPS diagnosis: percent (n)
 Brief Intermittent Psychotic (BIPS) 20% (4)
 Attenuated Positive Symptoms (APS) 75% (15)
 Genetic Risk & Deterioration (GRD) 5% (1)
Medication Status (n)
 Current atypical antipsychotic 4
 Current SSRI/SNRI 7
 Current mood stabilizer 2
 Current psychostimulant 2
 Current Other (cogentin, abilify, klonopin) 3
 No current medication 10
 One current medication 5
 Two current medications 4
 Three current medications 0
 Four current medications 1